BiomX Statistics
Share Statistics
BiomX has 18.18M shares outstanding. The number of shares has increased by -61.08% in one year.
Shares Outstanding | 18.18M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -74.36% |
Owned by Institutions (%) | n/a |
Shares Floating | 11.31M |
Failed to Deliver (FTD) Shares | 10.73K |
FTD / Avg. Volume | 12.43% |
Short Selling Information
The latest short interest is 23.03K, so 0.13% of the outstanding shares have been sold short.
Short Interest | 23.03K |
Short % of Shares Out | 0.13% |
Short % of Float | 0.21% |
Short Ratio (days to cover) | 0.74 |
Valuation Ratios
The PE ratio is -0.55 and the forward PE ratio is null.
PE Ratio | -0.55 |
Forward PE | null |
PS Ratio | -40.26 |
Forward PS | null |
PB Ratio | 4.66 |
P/FCF Ratio | -0.67 |
PEG Ratio | n/a |
Enterprise Valuation
BiomX Inc. has an Enterprise Value (EV) of 13.60M.
EV / Earnings | -0.52 |
EV / Sales | -38.1 |
EV / EBITDA | -0.6 |
EV / EBIT | -0.49 |
EV / FCF | -0.64 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 3.85.
Current Ratio | 1.58 |
Quick Ratio | 1.58 |
Debt / Equity | 3.85 |
Total Debt / Capitalization | 79.37 |
Cash Flow / Debt | -1.8 |
Interest Coverage | -11.52 |
Financial Efficiency
Return on equity (ROE) is -8.49% and return on capital (ROIC) is -152.48%.
Return on Equity (ROE) | -8.49% |
Return on Assets (ROA) | -1.05% |
Return on Capital (ROIC) | -152.48% |
Revenue Per Employee | -6.16K |
Profits Per Employee | -451.19K |
Employee Count | 58 |
Asset Turnover | -0.01 |
Inventory Turnover | 0 |
Taxes
Income Tax | 23.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -78.2% in the last 52 weeks. The beta is 1.32, so BiomX 's price volatility has been higher than the market average.
Beta | 1.32 |
52-Week Price Change | -78.2% |
50-Day Moving Average | 0.77 |
200-Day Moving Average | 2.38 |
Relative Strength Index (RSI) | 44.94 |
Average Volume (20 Days) | 86.31K |
Income Statement
In the last 12 months, BiomX had revenue of -$357.00K and earned -$26.17M in profits. Earnings per share was $-5.1.
Revenue | -357.00K |
Gross Profit | -1.23M |
Operating Income | -27.68M |
Net Income | -26.17M |
EBITDA | -22.82M |
EBIT | -27.68M |
Earnings Per Share (EPS) | -5.1 |
Balance Sheet
The company has $15.86M in cash and $15.09M in debt, giving a net cash position of $772.00K.
Cash & Cash Equivalents | 15.86M |
Total Debt | 15.09M |
Net Cash | 772.00K |
Retained Earnings | -162.97M |
Total Assets | 59.98M |
Working Capital | 19.37M |
Cash Flow
In the last 12 months, operating cash flow was -$21.29M and capital expenditures -$50.00K, giving a free cash flow of -$21.34M.
Operating Cash Flow | -21.29M |
Capital Expenditures | -50.00K |
Free Cash Flow | -21.34M |
FCF Per Share | -4.16 |
Margins
Gross margin is 343.98%, with operating and profit margins of 7.75K% and 7.33K%.
Gross Margin | 343.98% |
Operating Margin | 7.75K% |
Pretax Margin | 7.32K% |
Profit Margin | 7.33K% |
EBITDA Margin | 6.39K% |
EBIT Margin | 7.75K% |
FCF Margin | 5.98K% |
Dividends & Yields
PHGE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -809.52% |
FCF Yield | -186.32% |
Analyst Forecast
The average price target for PHGE is $22.5, which is 3471.4% higher than the current price. The consensus rating is "Buy".
Price Target | $22.5 |
Price Target Difference | 3471.4% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Stock Splits
The last stock split was on Aug 26, 2024. It was a backward split with a ratio of 1:10.
Last Split Date | Aug 26, 2024 |
Split Type | backward |
Split Ratio | 1:10 |
Scores
Altman Z-Score | -3.49 |
Piotroski F-Score | 3 |